ArticleOncoTargets and therapy2019

Retrospective analysis of sorafenib efficacy and safety in Chinese patients with high recurrence rate of post-hepatic carcinectomy.

Desheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.